bluebird bio, Inc. (BLUE) was a big mover last session, as the company saw its shares surge over 10% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down about 16.7% in the past one-month time frame.
Although the company has seen 1 upward revision in the past one month, its Zacks Consensus Estimate of a loss widened over the same period, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
bluebird bio currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same industry include Alexion Pharmaceuticals, Inc. (ALXN), Biogen Idec Inc. (BIIB) and BioMarin Pharmaceutical Inc. (BMRN), all with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
BLUEBIRD BIO INC (BLUE): Free Stock Analysis Report
ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
BIOMARIN PHARMA INC (BMRN): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry
- Personal Investing Ideas & Strategies